Overview Rating

Speculative

Technicals Analysis

100

0100

Financials Analysis

0100

AbbVie (NYSE:ABBV) Stock Quotes, Forecast and News Summary

Q: What sector and industry does AbbVie (ABBV) operate in?

AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

AbbVie Stock (NYSE: ABBV) stock price, news, charts, stock research, profile.

Open	$168.63
Close	$165.96
Volume / Avg.	5.97M / 5.65M
Day Range	165.45 - 168.63
52 Wk Range	132.70 - 182.89
Market Cap	$293.08B
P/E Ratio	50.71
Dividend Yield	3.64%
Exchange	NYSE
RSI	47
Short Interest	0.86%
Days to Cover	3.5

Recent News

Merck's Lung Cancer Candidate Faces FDA Rejection

Merck (NYSE: MRK) and its partner Daiichi Sankyo announced that the FDA has issued a complete response letter ("CRL") to the biologics license application (BLA) seeking accelerated approval for patritumab deruxtecan for previously-treated EGFR-mutated non-small cell lung cancer (NSCLC).

Zacks

AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway

The FDA has approved Epkinly as the first subcutaneously administered bispecific antibody for adults with relapsed or refractory follicular lymphoma after two or more lines of prior therapy.

Vandana Singh

AbbVie's Parkinson's Disease Therapy Hits FDA Roadblock

AbbVie received an FDA Complete Response Letter for ABBV-951 (foscarbidopa/foslevodopa) due to third-party manufacturing issues. ABBV-951, a treatment for advanced Parkinson's, is approved in 34 countries.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Jun

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Abbvie Inc

Sector

Health Care

Industry

Biotechnology

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinv...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy AbbVie (ABBV) stock?

You can purchase shares of AbbVie (NYSE:ABBV) through any online brokerage.

View our list of the best stock brokerages

Who are AbbVie (ABBV) competitors?

Other companies in AbbVie’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).

What is the target price for AbbVie (ABBV) stock?

There is no analysis for AbbVie.

What is the forecast for AbbVie (ABBV) stock?

AbbVie has a consensus price target of $149.58.

Current stock price for AbbVie (ABBV)?

The stock price for AbbVie (NYSE: ABBV) is $165.97 last updated July 2, 2024 at 6:56 PM EDT.

Does AbbVie (ABBV) pay a dividend?

The next AbbVie (ABBV) dividend date is projected to be Monday, July 15, 2024.

When is AbbVie (NYSE:ABBV) reporting earnings?

AbbVie’s Q2 earnings are confirmed for Thursday, July 25, 2024.

Is AbbVie (ABBV) going to split?

There is no upcoming split for AbbVie.

What sector and industry does AbbVie (ABBV) operate in?

AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

AbbVie

AbbVie (ABBV) Forecast